Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	1 Placebo
Total, all-cause mortality	2 Gabapentin Low
Total, all-cause mortality	3 Gabapentin Medium
Total, all-cause mortality	4 Gabapentin High
Total, other adverse events	1 Placebo	30	44
Total, other adverse events	2 Gabapentin Low	21	42
Total, other adverse events	3 Gabapentin Medium	27	41
Total, other adverse events	4 Gabapentin High	25	43
Total, serious adverse events	1 Placebo	1	44
Total, serious adverse events	2 Gabapentin Low	1	42
Total, serious adverse events	3 Gabapentin Medium	4	41
Total, serious adverse events	4 Gabapentin High	4	43

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00414466/event-totals